These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9803251)

  • 1. Should we be screening blood donors for hepatitis G virus? The case against screening.
    Wong PY; Coghlan PJ; Angus PW
    Med J Aust; 1998 Oct; 169(7):375-7. PubMed ID: 9803251
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we be screening blood donors for hepatitis G virus? The case for screening.
    Moaven LD
    Med J Aust; 1998 Oct; 169(7):373-4. PubMed ID: 9803250
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibodies to the E2 protein of hepatitis G virus in blood donors in New Zealand.
    Woodfield G; Roberts M
    N Z Med J; 1998 Nov; 111(1078):459-60. PubMed ID: 9891569
    [No Abstract]   [Full Text] [Related]  

  • 4. Proper donor screening--a good prevention of transfusion transmitted AIDS and hepatitis.
    Chatterjee K
    J Acad Hosp Adm; 1994 Jul; 6(2):49-52. PubMed ID: 10537998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis G virus exists--but does hepatitis G?].
    Wejstål R; Lindberg J
    Lakartidningen; 1999 Jan; 96(4):323-6. PubMed ID: 10024820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of hepatitis G virus among Tunisian blood donors].
    Mastouri M; Safer IL; Pozzetto B; Bourlet T; Khedher M
    East Mediterr Health J; 2005; 11(5-6):1053-60. PubMed ID: 16761677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus.
    Tan D; Matsumoto A; Conry-Cantilena C; Melpolder JC; Shih JW; Leuther M; Hess G; Gibble JW; Ness PM; Alter HJ
    J Infect Dis; 1999 May; 179(5):1055-61. PubMed ID: 10191204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components.
    Hitzler WE; Runkel S
    Clin Lab; 2004; 50(1-2):25-31. PubMed ID: 15000218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis G virus infection in hemodialysis patients: fact or fancy?
    Macedo G; Pereira O; Carvalho B; Loureiro A
    Am J Gastroenterol; 1999 May; 94(5):1423-4. PubMed ID: 10235242
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis GB virus C/hepatitis G virus infection in blood donors in India.
    Thakur V; Guptan RC; Sarin SK
    J Assoc Physicians India; 2000 Aug; 48(8):818-9. PubMed ID: 11273477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
    Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening blood donors for HTLV-1: a case for a cost-benefit analysis.
    West Indian Med J; 1990 Sep; 39(3):195-6. PubMed ID: 2124755
    [No Abstract]   [Full Text] [Related]  

  • 14. [GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance].
    Sarrazin C; Roth WK; Zeuzem S
    Z Gastroenterol; 1998 Nov; 36(11):997-1008. PubMed ID: 9880826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum pooling for screening of blood donors for hepatitis C virus antibody.
    Kini S; Kumar S; Sharma RR; Thakral B; Agnihotri SK
    Indian J Pathol Microbiol; 2003 Jul; 46(3):537-8. PubMed ID: 15025337
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous detection of hepatitis B, C, and G viral genomes by multiplex PCR method.
    Konomi N; Yamaguchi M; Naito H; Aiba N; Saito T; Arakawa Y; Abe K
    Jpn J Infect Dis; 2000 Apr; 53(2):70-2. PubMed ID: 10871918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis G virus or hepatitis GB virus C].
    Heinsen A; Fomsgaard A
    Ugeskr Laeger; 1999 May; 161(18):2653-6. PubMed ID: 10434784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GPT limit values in blood donors: lower, higher or eliminate completely?].
    Caspari G; Gerlich WH
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):142-4. PubMed ID: 7640508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.